COSMED Nordic ApS
CVR: 40958169
Secondary names: Innovision ApS, PulmoTrace ApS, InnoCC ApS
COSMED Nordic ApS is currently facing significant financial challenges, with a declining revenue trend from 10.1 million DKK in 2022 to 7.16 million DKK in 2024, alongside increasing losses. The company reported a profit loss of 1.35 million DKK in 2024, marking a substantial deterioration from a loss of 544,761 DKK in 2023. Its equity position has also worsened, dropping to -4.93 million DKK, indicating ongoing financial instability. With its focus on manufacturing radiation and electromedical equipment, COSMED Nordic ApS is struggling to establish a strong foothold in a competitive industry, raising concerns about its long-term viability.
AI-generated summary
Overview
- Company type
- APS
- Anpartsselskab
- Founded
- 25.11.2019
Details
- Capital
- 5.500 €
Contact
Advertising protected- Phone
- Log in to see
- Log in to see
- Website
- www.cosmed.com
Purpose
Selskabets formål er at drive forskning, udvikling og salg af medikoteknikse apparater og hermed beslægtet virksomhed.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 7.2 mio. | -1.4 mio. | 8 mio. | -4.9 mio. | 4 | |
History
Ownership
Management
Directors
Board
Founders
Production units (1)
Similar companies
Companies in the same industry and area